Robotics to Be the Driving Force Behind J&J’s Device Unit

Johnson & Johnson is slated to offer a preview of its surgical robotics solution strategy in May during its Medical Device Business Review Day in New York.

Johnson & Johnson is offering a preview of its surgical robotics strategy  May 13th during its Medical Device Business Review Day in New York. Executives of the New Brunswick, NJ-based company announced the date during a call discussing its 4Q19 results on Wednesday.

Alex Gorsky, J&J’s CEO noted that going forward surgical robotics would be a driving force behind the company’s medtech division.

“As it relates to medical devices, we’ve been, I think, very consistent in sharing our thinking that, again, this next generation is certainly about the robotics component that helps facilitate perhaps having more consistency in an exact procedure, perhaps getting into a tighter space, having better access,” Gorsky said, according to a Seeking Alpha transcript of the earnings call.

The news follows the healthcare giant buying out Verily’s interest in the Verb Surgical joint venture for an undisclosed sum. The Verb buyout is one of two major developments that occurred last year that are set to power J&J’s upcoming surgical robotics platform. The second development is J&J’s acquisition of Auris Health.

Redwood City, CA-based Auris Health develops robotic technologies that have been focused on lung cancer. The firm has the Monarch Platform, an FDA-cleared system currently used in bronchoscopic diagnostic and therapeutic procedures.

Gorsky spoke about how both Verb and Auris play into the May 13th preview.

“We think combining Auris and Verb really helps ensure that we have a very strong role in the next-generation of the digital surgery platform and ongoing development,” Gorsky said according to a Seeking Alpha transcript of the earnings call. “Our teams are working now together in a really comprehensive way.

By Omar Ford | MD+DI

Image Credit: Omar Ford / MD+DI


About Peter Coffaro 487 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 25 years of progressive management success within the medical device industry. Recognized by the World Journal of Orthopedics, Exponential Healthtech, and as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager, Distributor, and Vice President. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy, and Stryker. He is also the founder of OrthoFeed: a popular blog that covers digital orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing, and professional education. Peter holds a B.S. degree in Biology and Chemistry from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.